ArticleCancer chemotherapy and pharmacology2021

Targeting cPLA2α inhibits gastric cancer and augments chemotherapy efficacy via suppressing Ras/MEK/ERK and Akt/β-catenin pathways.

Yingying Liao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.